Enzon Pharmaceuticals Inc
(ENZN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-1982 | 12-1981 | |
| Operating Expenses | 8 | 3 |
| Operating Income | -8 | -3 |
| Pre-tax Income | -8 | -3 |
| Net Income Continuous | -8 | -3 |
| Net Income | $-8 | $-3 |
| EPS Basic Total Ops | -0.01 | N/A |
| EPS Basic Continuous Ops | -0.01 | N/A |
| EPS Diluted Total Ops | -0.01 | N/A |
| EPS Diluted Continuous Ops | -0.01 | N/A |
| EBITDA(a) | $-8 | $-3 |